Targeting capacity, safety and efficacy of engineered extracellular vesicles delivered by transdermal microneedles to treat plasmacytoma in mice

Documenti analoghi

• Surface engineering enhances the therapeutic potential of systemically delivered extracellular vesicles following acute myocardial infarction
  di: Kyle I. Mentkowski, et al.
  Pubblicazione: (2024)
• Numerical study of doxorubicin transdermal delivery for breast cancer treatment using microneedles
  di: Houda Barhoumi, et al.
  Pubblicazione: (2024)
• Human adipose mesenchymal stem cell derived extracellular vesicles‐delivered HSP27 alleviates UVB ‐induced photoaging
  di: Qianwen Zeng, et al.
  Pubblicazione: (2025)
• Dynamics of extracellular vesicle uptake by mural granulosa cells in mice
  di: Taichi Edure, et al.
  Pubblicazione: (2024)
• Increased levels of extracellular matrix proteins associated with extracellular vesicles from brains of aged mice
  di: Azariah K. Kaplelach, et al.
  Pubblicazione: (2024)